And with data showing the effectiveness of weight-loss medications*, we wanted to help make them accessible to eligible individuals by connecting them to independent, licensed providers**
Here are some popular Semaglutide alternatives: Tirzepatide: Tirzepatide is a novel medication that is FDA approved for the treatment of type 2 diabetes mellitus
William Seeds uses the following protocols depending on which variation of CJC-1295 is being administered: CJC-1295 WITHOUT DAC: A saturation dose of 100 mcg is typically used (1 mg/kg), as any higher dosage adds minimally to the pulse of GH released CJC-1295 WITH DAC: Twice a week at 100 mcg, OR 100 mcg daily (this dose works best for short-term treatment to elevate IGF1 above physiologic levels) He also recommends avoiding food consumption 30 minutes before GHRH use and 1.5 hours after using it (due to carbs and fats blunting GH release), and therefore its best to take it either before bed (thus improving sleep) or in the morning before your first meal
All tirzepatide doses were more efficacious than GLP-1 RAs in achieving a body weight loss of at least 10% and 15% (ESM Table 2)
The drug hydroxyurea (Hydrea), which is often used to treat painful crises in sickle cell anemia, may be of benefit in some thalassemia patients (Rund 2005)